Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Biotechnology 75 13.8%
Current Price (02/27) $310.08
CAPS Rating (Rate this stock on CAPS) Foolcaps 3
Expected Income Statement
Current Sales 14,377.9
Sales Growth Forecast 7.0%
Net Profit Margin 43.9%
Projected Shares Outstanding 180.00
EPS - Five year Forecast $49.22
Average P/E Ratio 12.0
Projected Average Price $590.63
Price Appreciation (Annualized) 13.8%
Annual Dividend Yield 0.0%
Projected Annual Return 13.8%
Quality
Financial Strength 62 15.4
EPS Stability 79 19.7
Industry Sales Growth Rate 16.5% 5.3
Industry Net Profit Margin 29.0% 18.9
Calculated Quality Rating 59.3
Fool CAPS

Total Players

973 Outperforms
76 Underperforms
 

All-Stars (225)

208 Outperforms (92%)
17 Underperforms
 
Fundamental Data Updated: 01/03/2020

MIPAR 10.8%  
Sweet Spot 15.8% - 20.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 95 19.2%
REGN 81 18.8%
BIIB 75 13.8%
AMGN 88 10.5%
CBPO 72 13.2%

Top In Healthcare

Ticker Quality PAR
ALGN 98 19.6%
JAZZ 95 19.2%
ABBV 91 19.2%
UNH 96 15.8%
REGN 81 18.8%